http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018143896-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37b416a8c0d2b0f1c3d6026d932027af http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97bd68cb0a98913a5940c708e7ce1679 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4727 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-96486 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57449 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
filingDate | 2018-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16061bf9526b3a148104e1169a44e509 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea06ad00b2c5fb22bce6009064418009 |
publicationDate | 2018-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2018143896-A1 |
titleOfInvention | Ovarian cancer biomarker |
abstract | Described herein is a method of detecting ovarian cancer and monitoring, prognosing, choosing a therapy and determining the likelihood of success of a particular therapy in an individual suffering from ovarian cancer. The methods comprise detecting the level of expression, activity or amount of MMP9 polypeptide (GenBank Accession Number: NP_004985-2) in an Annexin V binding microparticle in a sample of or from an individual suspected to be suffering or is suffering from ovarian cancer, wherein the microparticle comprises microvesicles, exosomes, ectosomes or apoptotic bodies. |
priorityDate | 2017-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 83.